• Nose spray treatment for cyanide poisoning

    The first nose spray treatment for the life-threatening effects of cyanide poisoning will be developed under an agreement between HHS and Response and Emergent BioSolutions of Gaithersburg, Maryland. The treatment is needed because cyanide could be used as a chemical weapon against the United States, according to the agency.

  • Cleaning up subways after release of biological warfare agent such as anthrax

    If you’re like most people, you don’t spend much time thinking about what would happen if anthrax was released into your local subway system. But Sandia Lab engineer Mark Tucker has spent much of the past twenty years thinking about incidents involving chemical or biological warfare agents, and the best ways to clean them up. Tucker’s current project focuses on cleaning up a subway system after the release of a biological warfare agent such as anthrax.

  • Lax policies governing dual-use research, scientists unaware of research’s biosecurity implications

    The National Academies of Sciences has examined policies and practices governing dual-use research in the life sciences – research that could potentially be misused to cause harm – and its findings identify multiple shortcomings. While the United States has a solid record in conducting biological research safely, the policies and regulations governing the dissemination of life sciences information that may pose biosecurity concerns are fragmented. Evidence also suggests that most life scientists have little awareness of biosecurity issues, the report says, stressing the importance of ongoing training for scientists.

  • Map shows how to disable dangerous bioweapon

    The Centers of Disease Control (CDC) ranks tularemia as one of the six most concerning bioterrorism agents, alongside anthrax, botulism, plague, smallpox and viral hemorrhagic fever. And Russian stockpiles of it likely remain. American scientists studying F. tularensis recently mapped out the complex molecular circuitry that enables the bacterium to become virulent. The map reveals a unique characteristic of the bacteria that could become the target of future drug development.

  • New biosecurity initiative to advance benefits, reduce risks of life sciences research

    A new biosecurity initiative at Stanford’s Freeman Spogli Institute for International Studies (FSI) aims to identify and mitigate biological risks, both natural and man-made, and safeguard the future of the life sciences and associated technologies. The biosecurity initiative will seek to advance the beneficial applications of the life sciences while reducing the risks of misuse by promoting research, education and policy outreach in biological security.

  • Biosecurity and synthetic biology: it is time to get serious

    By Eric van der Helm

    Synthetic biology has only been recently recognized as a mature subject in the context of biological risk assessment — and the core focus has been infectious diseases. In the case of biosecurity, we’re already dependent on biology [with respect to food, health etc.] but we still have an opportunity to develop biosecurity strategies before synthetic biology is ubiquitous. There is still an opportunity to act now and put norms and practices in place because the community is still relatively small. “If scientists are not taking care of biosecurity now, other people will start taking care of it, and they most likely will start preventing researchers from doing good science.”

  • Distinguishing virulent from harmless bacteria to help biological surveillance

    Biological “detectives” are tracking down biothreats such as the bacteria that causes tularemia (“rabbit fever”), but they constantly face the challenge of avoiding false positives. Sounding the alarm over a bioattack, only to find it’s a harmless relative in the same genus, reduces credibility and public trust. Researchers are narrowing down the confusion over Francisella bacteria, a few species of which include highly virulent human and animal pathogens, fish pathogens, opportunistic human pathogens, tick endosymbionts, and free-living isolates inhabiting brackish water.

  • Identifying vulnerabilities posed by synthetic biology

    Given the possible security vulnerabilities related to developments in synthetic biology – a field that uses technologies to modify or create organisms or biological components – a new report by the National Academies of Sciences proposes a framework to identify and prioritize potential areas of concern associated with the field. “While biotechnology is being pursued primarily for beneficial and legitimate purposes, there are potential uses that are detrimental to humans, other species, and ecosystems,” says one of the report’s authors.

  • Making gene editing safer

    Gene editing technologies have captured increasing attention from healthcare professionals, policymakers, and community leaders in recent years for their potential to cure disease, control mosquito populations, and much more. The potential national security applications and implications of these technologies are equally profound, including protection of troops against infectious disease, mitigation of threats posed by irresponsible or nefarious use of biological technologies, and enhanced development of new resources derived from synthetic biology, such as novel chemicals, materials, and coatings with useful, unique properties. DARPA is funding the efforts of seven teams aiming to develop new knowledge and tools to support responsible innovation in gene editing and protect against threats to genome integrity.

  • Bolstering counter-WMD capabilities in the southeast Europe and Black Sea regions

    The Defense Threat Reduction Agency’s (DTRA) DIABLO SHIELD training event and field exercise took place in Tblisi, Georgia, 24-28 April. DIABLO SHIELD emphasizes countering biological threats, and is part of the U.S. European Command’s (USEUCOM) Diablo Pathways series of engagements that support the development of counter-WMD capabilities in the southeast Europe and Black Sea regions.

  • Stacking countermeasures for layered defense against chemical, biological threats

    Just as we must protect computer systems against assaults in the form of viruses and trojans in the cyber world, we must protect our soldiers from a multitude of chemical and biological threats on the battlefield. No one countermeasure can mitigate every threat, which is why the Joint Science and Technology Office at the Defense Threat Reduction Agency is developing a portfolio of novel capabilities and medical countermeasures to protect our troops.

  • Lawmaker criticizes closure of biodefense lab

    President Trump’s FY2018 budget, released last week, zeroes out funding for the National Biodefense Analysis and Countermeasures Center (NBACC) in Frederick, Maryland and calls for its closure. NBACC, operated by DHS, supports preparedness planning, intelligence assessments and bio-forensic analysis. The lab often assists the FBI in investigating bioterrorism and bio-crime and employs over 180 people.

  • Urban legend: WWI-era “viable” anthrax strain was, in fact, much younger standard laboratory strain

    A team of international researchers has found that a strain of anthrax-causing bacterium thought to have been viable eighty years after a thwarted First World War espionage attack, was, in reality, a much younger standard laboratory strain. The team speculates that the mix-up was due to commonplace laboratory contamination. In 1917, German spy Baron Otto von Rosen was caught in Norway possessing lumps of sugar embedded with glass capillaries filled with a liquid holding spores of Bacillus anthracis, the bacterium that causes anthrax. He was suspected of plotting to feed the sugar lumps, which contained the oldest known isolates of B. anthracis, to the reindeer that pulled transports of munitions and foods across the frozen Arctic tundra for the Allied forces.

  • International anthrax conference will explore latest scientific research findings

    Scientists and researchers from all over the world who work on Bacillus anthracis, the causative agent of anthrax, and B. cereus and B. thuringiensis, two closely related bacillus species, will be heading to Victoria, British Columbia, in October for the international conference known as “Bacillus ACT.” The bi-annual conference, set for 1-5 October, will allow members of the scientific community to present their work and meet more than 200 global peers.

  • Bioterrorists, using genetic editing, could kill more than 30 million people: Bill Gates

    A bioterrorist attack could kill thirty million people — and such an attack is becoming more likely because it has become much easier to create – or “design” — deadly pathogens and spread them. Bill Gates, Microsoft founder, speaking in London, said that an outbreak of a lethal respiratory virus like smallpox would be more dangerous than even a nuclear attack. Anyone can now purchase chemistry kits which allow genetic editing, and do so online for under $150.